One of the biggest challenges in managing AAA and PAD is the unpredictability of disease progression. For instance, while ...
2d
Discover how AI tools like AlphaFold and RF Diffusion are revolutionizing protein folding design, medicine, and ...
Background Cardiovascular disease (CVD) remains a significant public health challenge in China. This study aimed to project ...
AZoLifeSciences on MSN9h
CRISPR-Cas9 Off-Target Effects: Challenges and SolutionsThe CRISPR-Cas9 system offers groundbreaking genome editing capabilities, yet off-target cleavage raises concerns about ...
A new research paper was published in Aging (Aging-US) on January 3, 2025, in Volume 17, Issue 1, titled “Characterization of ...
Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the ...
Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the ...
Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCCAmezalpat builds momentum with both ...
As global air traffic continues to grow, the aviation industry faces mounting pressure to reduce aircraft noise ...
You may not have heard of Ansys, but it's in the process of being acquired by chip design tool firm Synopsys for $35 billion.
CA is commonly used in disease prediction models, yet it fails to capture the variability in biological aging across individuals. The study excluded individuals with pre-existing conditions such ...
A team of researchers from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has developed a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback